SBWIC
PFE icon

Schaper Benz & Wise Investment Counsel’s Pfizer PFE Stock Holding History

Schaper Benz & Wise Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51M Sell
187,450
-10,750
-5% -$281K 0.3% 78
2026
Q1 		$5.57M Sell
198,200
-3,905
-2% -$104K 0.43% 69
2025
Q4 		$5.03M Sell
202,105
-2,627
-1% -$66.2K 0.36% 70
2025
Q3 		$5.22M Sell
204,732
-1,172
-0.6% -$28.9K 0.39% 67
2025
Q2 		$4.99M Buy
205,904
+5,125
+3% +$120K 0.38% 71
2025
Q1 		$5.09M Buy
200,779
+339
+0.2% +$8.87K 0.41% 68
2024
Q4 		$5.32M Sell
200,440
-351
-0.2% -$9.52K 0.43% 69
2024
Q3 		$5.81M Sell
200,791
-2,577
-1% -$75.2K 0.46% 63
2024
Q2 		$5.69M Buy
203,368
+1,495
+0.7% +$41.2K 0.49% 61
2024
Q1 		$5.6M Sell
201,873
-6,438
-3% -$179K 0.47% 63
2023
Q4 		$6M Sell
208,311
-5,153
-2% -$156K 0.54% 60
2023
Q3 		$7.08M Sell
213,464
-2,350
-1% -$83.1K 0.7% 56
2023
Q2 		$7.92M Buy
215,814
+140
+0.1% +$5.45K 0.76% 50
2023
Q1 		$8.8M Sell
215,674
-1,877
-0.9% -$81.1K 0.89% 46
2022
Q4 		$11.1M Sell
217,551
-7,363
-3% -$353K 1.18% 37
2022
Q3 		$9.84M Sell
224,914
-1,720
-0.8% -$83.6K 1.14% 39
2022
Q2 		$11.9M Sell
226,634
-3,167
-1% -$161K 1.22% 36
2022
Q1 		$11.9M Sell
229,801
-1,300
-0.6% -$67.5K 1.03% 43
2021
Q4 		$13.6M Sell
231,101
-1,450
-0.6% -$71.8K 1.1% 41
2021
Q3 		$10M Buy
232,551
+136
+0.1% +$6.03K 0.9% 45
2021
Q2 		$9.1M Sell
232,415
-1,290
-0.6% -$50.2K 0.82% 48
2021
Q1 		$8.47M Buy
233,705
+9,204
+4% +$327K 0.83% 49
2020
Q4 		$8.26M Sell
224,501
-8,757
-4% -$321K 0.86% 47
2020
Q3 		$8.12M Sell
233,258
-4,974
-2% -$174K 0.95% 46
2020
Q2 		$7.39M Buy
238,232
+558
+0.2% +$19K 0.92% 46
2020
Q1 		$7.36M Buy
237,674
+7,410
+3% +$252K 1.07% 44
2019
Q4 		$8.56M Buy
230,264
+1,839
+0.8% +$65.5K 1% 43
2019
Q3 		$7.79M Buy
228,425
+4,895
+2% +$178K 0.97% 44
2019
Q2 		$9.19M Sell
223,530
-1,312
-0.6% -$52.1K 1.16% 40
2019
Q1 		$9.06M Sell
224,842
-7,220
-3% -$289K 1.18% 38
2018
Q4 		$9.61M Sell
232,062
-8,914
-4% -$370K 1.44% 31
2018
Q3 		$10.1M Buy
240,976
+1,233
+0.5% +$47.5K 1.35% 32
2018
Q2 		$8.25M Buy
239,743
+538
+0.2% +$18.4K 1.18% 36
2018
Q1 		$8.05M Hold
239,205
– – 1.19% 36
2017
Q4 		$8.22M Buy
239,205
+2,108
+0.9% +$71.9K 1.2% 35
2017
Q3 		$8.03M Buy
237,097
+6,416
+3% +$206K 1.25% 35
2017
Q2 		$7.35M Buy
230,681
+1,371
+0.6% +$43.2K 1.18% 35
2017
Q1 		$7.44M Hold
229,310
– – 1.27% 35
2016
Q4 		$7.07M Sell
229,310
-4,449
-2% -$136K 1.25% 35
2016
Q3 		$7.51M Buy
233,759
+4,031
+2% +$135K 1.32% 36
2016
Q2 		$7.67M Buy
229,728
+2,467
+1% +$78.7K 1.38% 32
2016
Q1 		$6.39M Buy
227,261
+2,582
+1% +$73.8K 1.2% 35
2015
Q4 		$6.88M Buy
224,679
+1,212
+0.5% +$38.1K 1.35% 31
2015
Q3 		$6.66M Sell
223,467
-1,069
-0.5% -$34.3K 1.35% 32
2015
Q2 		$7.14M Sell
224,536
-9,732
-4% -$317K 1.4% 34
2015
Q1 		$7.73M Buy
234,268
+982
+0.4% +$31.2K 1.52% 33
2014
Q4 		$6.89M Buy
233,286
+1,125
+0.5% +$32.3K 1.38% 33
2014
Q3 		$6.51M Buy
232,161
+1,027
+0.4% +$28.8K 1.36% 32
2014
Q2 		$6.51M Sell
231,134
-556
-0.2% -$15.8K 1.34% 33
2014
Q1 		$7.06M Sell
231,690
-887
-0.4% -$26.4K 1.53% 32
2013
Q4 		$6.76M Sell
232,577
-5,039
-2% -$147K 1.51% 32
2013
Q3 		$6.48M Buy
237,616
+2,951
+1% +$80.3K 1.5% 35
2013
Q2 		$6.24M Buy
+234,665
New +$6.48M 1.54% 33

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's PFE Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel reduced its Pfizer (PFE) stake by 5.4% in Q2 2026, selling an estimated $281K and leaving 187,450 shares worth $4.51M. The position accounts for 0.3% of the portfolio, ranked #78.

Schaper Benz & Wise Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.6M in Q4 2021. 990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel held 187,450 shares of Pfizer worth $4.51M as of Q2 2026.
  • Schaper Benz & Wise Investment Counsel sold 10,750 Pfizer shares in Q2 2026, an estimated $281K.
  • Pfizer made up 0.3% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #78 holding.
  • Schaper Benz & Wise Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Schaper Benz & Wise Investment Counsel's Pfizer position peaked at $13.6M in Q4 2021.
  • 990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.